MDxHealth SA ROA 2018-2025 | MDXH
MDxHealth SA ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2025-03-31 | $-0.04B | $0.18B | -25.16% |
2024-12-31 | $-0.04B | $0.16B | -27.51% |
2024-09-30 | $-0.04B | $0.16B | -31.91% |
2024-06-30 | $-0.04B | $0.13B | -32.43% |
2024-03-31 | $-0.04B | $0.12B | -42.38% |
2023-12-31 | $-0.04B | $0.13B | -42.31% |
2023-06-30 | $-0.04B | $0.00B | -98.01% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.115B | $0.090B |
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
Doximity (DOCS) | United States | $11.317B | 52.39 |
Hims & Hers Health (HIMS) | United States | $10.654B | 110.70 |
Tempus AI (TEM) | United States | $10.042B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.327B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.691B | 57.67 |
Hinge Health (HNGE) | United States | $3.687B | 0.00 |
Privia Health (PRVA) | United States | $2.458B | 168.00 |
Schrodinger (SDGR) | United States | $1.674B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.583B | 0.00 |
Phreesia (PHR) | United States | $1.580B | 0.00 |
Enovis (ENOV) | United States | $1.502B | 8.38 |
Azenta (AZTA) | United States | $1.434B | 66.64 |
10x Genomics (TXG) | United States | $1.421B | 0.00 |
Omnicell (OMCL) | United States | $1.313B | 23.17 |
Evolent Health (EVH) | United States | $1.146B | 97.60 |
Claritev (CTEV) | United States | $0.705B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.540B | 0.00 |
Veradigm (MDRX) | United States | $0.498B | 0.00 |
Standard BioTools (LAB) | United States | $0.479B | 0.00 |
Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
Talkspace (TALK) | United States | $0.427B | 127.50 |
TruBridge (TBRG) | United States | $0.337B | 746.67 |
Outset Medical (OM) | United States | $0.310B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
CapsoVision (CV) | United States | $0.206B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.187B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
Pulmonx (LUNG) | United States | $0.128B | 0.00 |
American Well (AMWL) | United States | $0.125B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
CareCloud (CCLD) | United States | $0.100B | 3.81 |
Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
111 (YI) | China | $0.066B | 0.00 |
P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
HeartBeam (BEAT) | United States | $0.043B | 0.00 |
Zhongchao (ZCMD) | China | $0.027B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
Precipio (PRPO) | United States | $0.021B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |